T. Rowe Price Associates’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53K | Buy |
+35,278
| New | +$53K | ﹤0.01% | 2999 |
|
|
2024
Q2 | – | Sell |
-15,982
| Closed | -$21K | – | 3003 |
|
|
2024
Q1 | $21K | Hold |
15,982
| – | – | ﹤0.01% | 2926 |
|
|
2023
Q4 | $29K | Hold |
15,982
| – | – | ﹤0.01% | 2853 |
|
|
2023
Q3 | $27K | Buy |
15,982
+4,535
| +40% | +$7.66K | ﹤0.01% | 2833 |
|
|
2023
Q2 | $23K | Buy |
+11,447
| New | +$23K | ﹤0.01% | 2856 |
|